Infectious Disease Diagnostics Market to 2025 - Global Analysis and Forecasts Product (Kits & Reagents and Instruments), Disease Indication [HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, and Others), Test Location (Laboratory Testing and Point of Care Testing), End User (Hospitals, Pathology/Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others) and Geography
Report Code: TIPHE100001430 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Infectious diseases are caused by microorganisms such as bacteria, fungi, virus, and other organism species. Infectious disease diagnostics are the procedures utilized by hospitals, clinical laboratories, and others to detect or identify the foreign antigen/organism by using various diagnostic tools. This helps to identify the type of pathogen that has entered the patient's body as well as the degree of extent to which the infection is spread in the body. The diagnostic procedure may be carried out with the help of conventional diagnostic tests or point-of-care testing tools.
The growth of global infectious disease diagnostics market is expected to be driven by various factors such as increasing prevalence of infectious and vector-borne diseases, and advances in molecular and immunodiagnostics is expected to propel the growth of the global infectious disease diagnostics market. However, absence of compiled regulatory guidelines and lack of centralized laboratory facilities in developing and under-developed laboratories are expected to hinder the market growth at certain extent. On the other hand, the immunodiagnostic kits and home-based point-of-care diagnostic tools for detection of various diseases is expected to be one of the most prevalent trend in the infectious disease diagnostics market.
The "Global Infectious Disease Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global infectious disease diagnostics market with detailed market segmentation by product, disease indication, technology, test location, end user and geography. The global infectious disease diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, test location, end user. On the basis of product, the global infectious disease diagnostics market is segmented into reagents & kits and instruments. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare associated infections (HIAs), human papillomavirus (HPV), tuberculosis, influenza, and others. Based on the technology, the market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), and others. On the basis of test location, the global infectious disease diagnostics market is segmented in to laboratory testing and point-of-care testing. Similarly, on the basis of end user, the global infectious disease diagnostics market is segmented in to hospitals, pathology/diagnostic laboratories, research institutes, home care settings and others.
The infectious disease diagnostics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infectious disease diagnostics market based on technology, disease indication and end user. It also provides market size and forecast till 2025 for overall infectious disease diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global infectious disease diagnostics market. This is primarily attributed to the advancements in the diagnostic tools and technologies, increasing prevalence of infectious diseases, and presence of highly developed healthcare infrastructure in this region. Asia Pacific on the other hand is expected to witness significant traction over the forecast period owing to the development of novel diagnostic products at affordable costs. The emerging economies in Asia Pacific such as India and China are expected to be the primary consumers of the diagnostic tests owing to lack of awareness regarding sanitation and hygiene in these countries leading to incidence of infectious diseases.
The infectious disease diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The infectious disease diagnostics market report also includes the profiles of leading infectious disease diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global infectious disease diagnostics market include Danaher, Abbott, BD, F. Hoffmann-La Roche Ltd, Trinity Biotech, Cardinal Health, bioMérieux SA, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and ACON Laboratories, Inc. among others.
The growth of global infectious disease diagnostics market is expected to be driven by various factors such as increasing prevalence of infectious and vector-borne diseases, and advances in molecular and immunodiagnostics is expected to propel the growth of the global infectious disease diagnostics market. However, absence of compiled regulatory guidelines and lack of centralized laboratory facilities in developing and under-developed laboratories are expected to hinder the market growth at certain extent. On the other hand, the immunodiagnostic kits and home-based point-of-care diagnostic tools for detection of various diseases is expected to be one of the most prevalent trend in the infectious disease diagnostics market.
The "Global Infectious Disease Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global infectious disease diagnostics market with detailed market segmentation by product, disease indication, technology, test location, end user and geography. The global infectious disease diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global infectious disease diagnostics market is segmented on the basis of product, disease indication, technology, test location, end user. On the basis of product, the global infectious disease diagnostics market is segmented into reagents & kits and instruments. Based on disease indication, the market is segmented into HIV, hepatitis, healthcare associated infections (HIAs), human papillomavirus (HPV), tuberculosis, influenza, and others. Based on the technology, the market is segmented into immunodiagnostics, polymerase chain reaction (PCR), next generation sequencing (NGS), and others. On the basis of test location, the global infectious disease diagnostics market is segmented in to laboratory testing and point-of-care testing. Similarly, on the basis of end user, the global infectious disease diagnostics market is segmented in to hospitals, pathology/diagnostic laboratories, research institutes, home care settings and others.
The infectious disease diagnostics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global infectious disease diagnostics market based on technology, disease indication and end user. It also provides market size and forecast till 2025 for overall infectious disease diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global infectious disease diagnostics market. This is primarily attributed to the advancements in the diagnostic tools and technologies, increasing prevalence of infectious diseases, and presence of highly developed healthcare infrastructure in this region. Asia Pacific on the other hand is expected to witness significant traction over the forecast period owing to the development of novel diagnostic products at affordable costs. The emerging economies in Asia Pacific such as India and China are expected to be the primary consumers of the diagnostic tests owing to lack of awareness regarding sanitation and hygiene in these countries leading to incidence of infectious diseases.
The infectious disease diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The infectious disease diagnostics market report also includes the profiles of leading infectious disease diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global infectious disease diagnostics market include Danaher, Abbott, BD, F. Hoffmann-La Roche Ltd, Trinity Biotech, Cardinal Health, bioMérieux SA, Bio-Rad Laboratories, Inc., AccuBioTech Co., Ltd., and ACON Laboratories, Inc. among others.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Infectious Disease Diagnostics Market - By Product
3.2.2. Infectious Disease Diagnostics Market - By Disease Indication
3.2.3. Infectious Disease Diagnostics Market - By Technology
3.2.4. Infectious Disease Diagnostics Market - By Test Location
3.2.5. Infectious Disease Diagnostics Market - By End User
3.2.6. Infectious Disease Diagnostics Market - By Region
3.2.6.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
5.6. CLINICAL TRIAL ANYLYSIS
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. KITS & REAGENTS MARKET
6.3.1. Overview
6.3.2. Kits & Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.4. INSTRUMENTS MARKET
6.4.1. Overview
6.4.2. Instruments Market Revenue Forecasts and Analysis (US$ Mn)
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HIV MARKET
7.3.1. Overview
7.3.2. HIV Market Revenue Forecasts and Analysis (US$ Mn)
7.4. HEPATITIS MARKET
7.4.1. Overview
7.4.2. Hepatitis Market Revenue Forecasts and Analysis (US$ Mn)
7.5. HEALTHCARE ASSOCIATED INFECTIONS MARKET
7.5.1. Overview
7.5.2. Healthcare Associated Infections Market Revenue Forecasts and Analysis (US$ Mn)
7.6. HUMAN PAPILLOMAVIRUS (HPV) MARKET
7.6.1. Overview
7.6.2. Human Papillomavirus (HPV)Market Revenue Forecasts and Analysis (US$ Mn)
7.7. TUBERCULOSIS MARKET
7.7.1. Overview
7.7.2. Tuberculosis Market Revenue Forecasts and Analysis (US$ Mn)
7.8. INFLUENZA MARKET
7.8.1. Overview
7.8.2. Influenza Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHERS MARKET
7.9.1. Overview
7.9.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. IMMUNODIAGNOSTICS MARKET
8.3.1. Overview
8.3.2. Immunodiagnostics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. POLYMERASE CHAIN REACTION (PCR) MARKET
8.4.1. Overview
8.4.2. Polymerase Chain Reaction (PCR) Market Revenue Forecasts and Analysis (US$ Mn)
8.5. NEXT GENERATION SEQUENCING (NGS) MARKET
8.5.1. Overview
8.5.2. Next Generation Sequencing (NGS) Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHERS MARKET
8.6.1. Overview
8.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TEST LOCATION
9.1. OVERVIEW
9.2. TEST LOCATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. LABORATORY TESTING MARKET
9.3.1. Overview
9.3.2. Laboratory Testing Market Revenue Forecasts and Analysis (US$ Mn)
9.4. POINT-OF-CARE TESTING MARKET
9.4.1. Overview
9.4.2. Point-of-Care Testing Market Revenue Forecasts and Analysis (US$ Mn)
10. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
10.1. OVERVIEW
10.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
10.3. HOSPITALS MARKET
10.3.1. Overview
10.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
10.4. PATHOLOGY/DIAGNOSTIC LABORATORIES MARKET
10.4.1. Overview
10.4.2. Pathology/Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
10.5. RESEARCH INSTITUTES MARKET
10.5.1. Overview
10.5.2. Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
10.6. HOME CARE SETTINGS MARKET
10.6.1. Overview
10.6.2. Home Care Settings Market Revenue Forecasts and Analysis (US$ Mn)
10.7. OTHERS MARKET
10.7.1. Overview
10.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
11. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
11.2. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
11.5. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.6. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
11.7. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.8. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.9. US MARKET OVERVIEW
11.9.1. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.9.3. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.4. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.9.5. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.10. CANADA MARKET OVERVIEW
11.10.1. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.10.2. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.10.3. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.10.4. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.10.5. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.11. MEXICO MARKET OVERVIEW
11.11.1. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.11.2. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.11.3. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.11.4. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.11.5. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
12.2. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
12.5. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.6. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
12.7. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.8. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.9. UK MARKET OVERVIEW
12.9.1. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.9.3. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.4. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.9.5. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.10. GERMANY MARKET OVERVIEW
12.10.1. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.10.2. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.10.3. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.10.4. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.10.5. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.11. FRANCE MARKET OVERVIEW
12.11.1. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.11.2. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.11.3. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.11.4. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.11.5. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.2. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.3. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
13.4. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.5. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
13.6. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.7. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.8. JAPAN MARKET OVERVIEW
13.8.1. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.2. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.8.3. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.8.4. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.8.5. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. CHINA MARKET OVERVIEW
13.9.1. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.9.2. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.9.3. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.9.4. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.9.5. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.10. INDIA MARKET OVERVIEW
13.10.1. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.10.2. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.10.3. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.10.4. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.10.5. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. MIDDLE EAST AND AFRICA (MEA) INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.2. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.3. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
14.4. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.5. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
14.6. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.7. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.8. SOUTH AFRICA MARKET OVERVIEW
14.8.1. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.8.2. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.8.3. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.8.4. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.8.5. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.9. SAUDI ARABIA MARKET OVERVIEW
14.9.1. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.9.2. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.9.3. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.9.4. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.9.5. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.10. UAE MARKET OVERVIEW
14.10.1. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.10.2. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.10.3. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.10.4. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.10.5. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
15.1. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
15.2. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
15.3. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
15.4. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
15.5. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
15.6. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
15.7. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
15.8. BRAZIL MARKET OVERVIEW
15.8.1. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
15.8.2. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
15.8.3. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
15.8.4. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
15.8.5. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
16. INDUSTRY LANDSCAPE
16.1. ORGANIC GROWTH STRATEGIES
16.1.1. New Product Launches
16.1.2. Marketing & Promotional Activities
16.2. INORGANIC GROWTH STRATEGIES
16.2.1. Partnerships, Collaborations, and Joint Ventures
16.2.2. Mergers & Acquisitions
17. INFECTIOUS DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
17.1. DANAHER
17.1.1. Key Facts
17.1.2. Business Description
17.1.3. Financial Overview
17.1.4. Product Portfolio
17.1.5. Product Pipeline
17.1.6. SWOT Analysis
17.1.7. Key Developments
17.2. ABBOTT
17.2.1. Key Facts
17.2.2. Business Description
17.2.3. Financial Overview
17.2.4. Product Portfolio
17.2.5. Product Pipeline
17.2.6. SWOT Analysis
17.2.7. Key Developments
17.3. BD
17.3.1. Key Facts
17.3.2. Business Description
17.3.3. Financial Overview
17.3.4. Product Portfolio
17.3.5. Product Pipeline
17.3.6. SWOT Analysis
17.3.7. Key Developments
17.4. F. HOFFMANN LA-ROCHE LTD
17.4.1. Key Facts
17.4.2. Business Description
17.4.3. Financial Overview
17.4.4. Product Portfolio
17.4.5. Product Pipeline
17.4.6. SWOT Analysis
17.4.7. Key Developments
17.5. TRINITY BIOTECH
17.5.1. Key Facts
17.5.2. Business Description
17.5.3. Financial Overview
17.5.4. Product Portfolio
17.5.5. Product Pipeline
17.5.6. SWOT Analysis
17.5.7. Key Developments
17.6. CARDINAL HEALTH
17.6.1. Key Facts
17.6.2. Business Description
17.6.3. Financial Overview
17.6.4. Product Portfolio
17.6.5. Product Pipeline
17.6.6. SWOT Analysis
17.6.7. Key Developments
17.7. BIOMÉRIEUX SA
17.7.1. Key Facts
17.7.2. Business Description
17.7.3. Financial Overview
17.7.4. Product Portfolio
17.7.5. Product Pipeline
17.7.6. SWOT Analysis
17.7.7. Key Developments
17.8. BIO-RAD LABORATORIES, INC.
17.8.1. Key Facts
17.8.2. Business Description
17.8.3. Financial Overview
17.8.4. Product Portfolio
17.8.5. Product Pipeline
17.8.6. SWOT Analysis
17.8.7. Key Developments
17.9. ACCUBIOTECH CO., LTD.
17.9.1. Key Facts
17.9.2. Business Description
17.9.3. Financial Overview
17.9.4. Product Portfolio
17.9.5. Product Pipeline
17.9.6. SWOT Analysis
17.9.7. Key Developments
17.10. ACON LABORATORIES, INC.
17.10.1. Key Facts
17.10.2. Business Description
17.10.3. Financial Overview
17.10.4. Product Portfolio
17.10.5. Product Pipeline
17.10.6. SWOT Analysis
17.10.7. Key Developments
18. APPENDIX
18.1. ABOUT THE INSIGHT PARTNERS
18.2. GLOSSARY OF TERMS
18.3. RESEARCH METHODOLOGY
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Infectious Disease Diagnostics Market - By Product
3.2.2. Infectious Disease Diagnostics Market - By Disease Indication
3.2.3. Infectious Disease Diagnostics Market - By Technology
3.2.4. Infectious Disease Diagnostics Market - By Test Location
3.2.5. Infectious Disease Diagnostics Market - By End User
3.2.6. Infectious Disease Diagnostics Market - By Region
3.2.6.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
5.6. CLINICAL TRIAL ANYLYSIS
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. KITS & REAGENTS MARKET
6.3.1. Overview
6.3.2. Kits & Reagents Market Revenue Forecasts and Analysis (US$ Mn)
6.4. INSTRUMENTS MARKET
6.4.1. Overview
6.4.2. Instruments Market Revenue Forecasts and Analysis (US$ Mn)
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. HIV MARKET
7.3.1. Overview
7.3.2. HIV Market Revenue Forecasts and Analysis (US$ Mn)
7.4. HEPATITIS MARKET
7.4.1. Overview
7.4.2. Hepatitis Market Revenue Forecasts and Analysis (US$ Mn)
7.5. HEALTHCARE ASSOCIATED INFECTIONS MARKET
7.5.1. Overview
7.5.2. Healthcare Associated Infections Market Revenue Forecasts and Analysis (US$ Mn)
7.6. HUMAN PAPILLOMAVIRUS (HPV) MARKET
7.6.1. Overview
7.6.2. Human Papillomavirus (HPV)Market Revenue Forecasts and Analysis (US$ Mn)
7.7. TUBERCULOSIS MARKET
7.7.1. Overview
7.7.2. Tuberculosis Market Revenue Forecasts and Analysis (US$ Mn)
7.8. INFLUENZA MARKET
7.8.1. Overview
7.8.2. Influenza Market Revenue Forecasts and Analysis (US$ Mn)
7.9. OTHERS MARKET
7.9.1. Overview
7.9.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. IMMUNODIAGNOSTICS MARKET
8.3.1. Overview
8.3.2. Immunodiagnostics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. POLYMERASE CHAIN REACTION (PCR) MARKET
8.4.1. Overview
8.4.2. Polymerase Chain Reaction (PCR) Market Revenue Forecasts and Analysis (US$ Mn)
8.5. NEXT GENERATION SEQUENCING (NGS) MARKET
8.5.1. Overview
8.5.2. Next Generation Sequencing (NGS) Market Revenue Forecasts and Analysis (US$ Mn)
8.6. OTHERS MARKET
8.6.1. Overview
8.6.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
9. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TEST LOCATION
9.1. OVERVIEW
9.2. TEST LOCATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
9.3. LABORATORY TESTING MARKET
9.3.1. Overview
9.3.2. Laboratory Testing Market Revenue Forecasts and Analysis (US$ Mn)
9.4. POINT-OF-CARE TESTING MARKET
9.4.1. Overview
9.4.2. Point-of-Care Testing Market Revenue Forecasts and Analysis (US$ Mn)
10. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
10.1. OVERVIEW
10.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
10.3. HOSPITALS MARKET
10.3.1. Overview
10.3.2. Hospitals Market Revenue Forecasts and Analysis (US$ Mn)
10.4. PATHOLOGY/DIAGNOSTIC LABORATORIES MARKET
10.4.1. Overview
10.4.2. Pathology/Diagnostic Laboratories Market Revenue Forecasts and Analysis (US$ Mn)
10.5. RESEARCH INSTITUTES MARKET
10.5.1. Overview
10.5.2. Research Institutes Market Revenue Forecasts and Analysis (US$ Mn)
10.6. HOME CARE SETTINGS MARKET
10.6.1. Overview
10.6.2. Home Care Settings Market Revenue Forecasts and Analysis (US$ Mn)
10.7. OTHERS MARKET
10.7.1. Overview
10.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
11. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
11.2. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
11.4. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
11.5. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.6. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
11.7. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.8. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.9. US MARKET OVERVIEW
11.9.1. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.9.2. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.9.3. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.9.4. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.9.5. US Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.10. CANADA MARKET OVERVIEW
11.10.1. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.10.2. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.10.3. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.10.4. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.10.5. Canada Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.11. MEXICO MARKET OVERVIEW
11.11.1. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.11.2. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.11.3. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.11.4. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
11.11.5. Mexico Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
12.2. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
12.4. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
12.5. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.6. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
12.7. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.8. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.9. UK MARKET OVERVIEW
12.9.1. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.9.2. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.9.3. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.9.4. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.9.5. UK Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.10. GERMANY MARKET OVERVIEW
12.10.1. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.10.2. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.10.3. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.10.4. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.10.5. Germany Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.11. FRANCE MARKET OVERVIEW
12.11.1. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.11.2. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.11.3. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.11.4. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
12.11.5. France Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.2. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
13.3. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
13.4. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.5. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
13.6. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.7. ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.8. JAPAN MARKET OVERVIEW
13.8.1. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.8.2. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.8.3. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.8.4. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.8.5. Japan Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.9. CHINA MARKET OVERVIEW
13.9.1. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.9.2. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.9.3. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.9.4. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.9.5. China Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13.10. INDIA MARKET OVERVIEW
13.10.1. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
13.10.2. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.10.3. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.10.4. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
13.10.5. India Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. MIDDLE EAST AND AFRICA (MEA) INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
14.1. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
14.2. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
14.3. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
14.4. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
14.5. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
14.6. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
14.7. MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
14.8. SOUTH AFRICA MARKET OVERVIEW
14.8.1. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.8.2. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.8.3. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.8.4. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.8.5. South Africa Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.9. SAUDI ARABIA MARKET OVERVIEW
14.9.1. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.9.2. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.9.3. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.9.4. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.9.5. Saudi Arabia Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14.10. UAE MARKET OVERVIEW
14.10.1. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
14.10.2. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
14.10.3. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
14.10.4. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
14.10.5. UAE Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
15. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
15.1. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
15.2. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY PRODUCT (US$ MN)
15.3. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
15.4. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
15.5. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TEST LOCATION (US$ MN)
15.6. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
15.7. SOUTH AND CENTRAL AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
15.8. BRAZIL MARKET OVERVIEW
15.8.1. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Product (US$ Mn)
15.8.2. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
15.8.3. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
15.8.4. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By Test Location (US$ Mn)
15.8.5. Brazil Infectious Disease Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
16. INDUSTRY LANDSCAPE
16.1. ORGANIC GROWTH STRATEGIES
16.1.1. New Product Launches
16.1.2. Marketing & Promotional Activities
16.2. INORGANIC GROWTH STRATEGIES
16.2.1. Partnerships, Collaborations, and Joint Ventures
16.2.2. Mergers & Acquisitions
17. INFECTIOUS DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
17.1. DANAHER
17.1.1. Key Facts
17.1.2. Business Description
17.1.3. Financial Overview
17.1.4. Product Portfolio
17.1.5. Product Pipeline
17.1.6. SWOT Analysis
17.1.7. Key Developments
17.2. ABBOTT
17.2.1. Key Facts
17.2.2. Business Description
17.2.3. Financial Overview
17.2.4. Product Portfolio
17.2.5. Product Pipeline
17.2.6. SWOT Analysis
17.2.7. Key Developments
17.3. BD
17.3.1. Key Facts
17.3.2. Business Description
17.3.3. Financial Overview
17.3.4. Product Portfolio
17.3.5. Product Pipeline
17.3.6. SWOT Analysis
17.3.7. Key Developments
17.4. F. HOFFMANN LA-ROCHE LTD
17.4.1. Key Facts
17.4.2. Business Description
17.4.3. Financial Overview
17.4.4. Product Portfolio
17.4.5. Product Pipeline
17.4.6. SWOT Analysis
17.4.7. Key Developments
17.5. TRINITY BIOTECH
17.5.1. Key Facts
17.5.2. Business Description
17.5.3. Financial Overview
17.5.4. Product Portfolio
17.5.5. Product Pipeline
17.5.6. SWOT Analysis
17.5.7. Key Developments
17.6. CARDINAL HEALTH
17.6.1. Key Facts
17.6.2. Business Description
17.6.3. Financial Overview
17.6.4. Product Portfolio
17.6.5. Product Pipeline
17.6.6. SWOT Analysis
17.6.7. Key Developments
17.7. BIOMÉRIEUX SA
17.7.1. Key Facts
17.7.2. Business Description
17.7.3. Financial Overview
17.7.4. Product Portfolio
17.7.5. Product Pipeline
17.7.6. SWOT Analysis
17.7.7. Key Developments
17.8. BIO-RAD LABORATORIES, INC.
17.8.1. Key Facts
17.8.2. Business Description
17.8.3. Financial Overview
17.8.4. Product Portfolio
17.8.5. Product Pipeline
17.8.6. SWOT Analysis
17.8.7. Key Developments
17.9. ACCUBIOTECH CO., LTD.
17.9.1. Key Facts
17.9.2. Business Description
17.9.3. Financial Overview
17.9.4. Product Portfolio
17.9.5. Product Pipeline
17.9.6. SWOT Analysis
17.9.7. Key Developments
17.10. ACON LABORATORIES, INC.
17.10.1. Key Facts
17.10.2. Business Description
17.10.3. Financial Overview
17.10.4. Product Portfolio
17.10.5. Product Pipeline
17.10.6. SWOT Analysis
17.10.7. Key Developments
18. APPENDIX
18.1. ABOUT THE INSIGHT PARTNERS
18.2. GLOSSARY OF TERMS
18.3. RESEARCH METHODOLOGY
The List of Companies
1 Danaher
2 Abbott
3 BD
4 F. Hoffmann-La Roche Ltd
5 Trinity Biotech
6 Cardinal Health
7 bioMérieux SA
8 Bio-Rad Laboratories, Inc.
9 AccuBioTech Co., Ltd.
10 ACON Laboratories, Inc.
1 Danaher
2 Abbott
3 BD
4 F. Hoffmann-La Roche Ltd
5 Trinity Biotech
6 Cardinal Health
7 bioMérieux SA
8 Bio-Rad Laboratories, Inc.
9 AccuBioTech Co., Ltd.
10 ACON Laboratories, Inc.